All posts by imreal

myButterfly.AI Announces Filing of Provisional Patent Application for Novel Medical Comprehension AI


myButterfly.AI, currently crowd funding on StartEngine, announced today that it has filed for a Pending Patent for it’s proprietary Medical Comprehension AI with the US PTO.

The patent application is directed to a novel method for explaining medical conversations between patients and their care givers. Based on published academic and other research sources, patient engagement is a key component in improving health outcomes. The same sources show that providing patients with relevant, understandable information and education is one path to activating them. myButterfly.ai believes that their ELI5 (Explain Like I’m 5) AI invention has the potential to educate patients as it comprehends complex terms and concepts into easy to understand language.

myButterfly.AI seeks to obtain patent protection for its technologies, as well as registering other intellectual property rights for its business and technology assets in the United States and internationally. myButterfly.AI aims to protect the technology, inventions and improvements that are commercially important to the development of its business using the most effective and efficient intellectual property instruments, including patents, trademarks and trade secrets.

This is the first of two pending patents in myButterfly.AI’s portfolio planned for this year. The patents are in two main areas, health and supply chain.

“It’s quite a bit of hard work and it is rewarding to see this design come together. This is an important step in securing our inventions so we can both protect our investors and deliver value to our users,” said CoFounder & CEO Sam Adams.

About myButterfly.AI

myButterfly.AI is a US based startup focusing on bringing the patient consumer choice and back to the center of the healthcare experience. It is designing a mobile AI app to help patients understand their care, and get access to the therapies they need at their preferred price points. The company believes that virtual, intelligent, personalized agents hold the potential to positively impact patient health experiences, outcomes and costs – for all parties involved .

Note to Editors: The following disclaimer should be included in any content covering this raise per SEC Regulation regarding Reg CF Equity Crowdfunding:

DISCLAIMER: myButterfly.AI is offering securities through the use of an Offering Statement that has been qualified by the Securities and Exchange Commission under Regulation CrowdFunding. A copy of the Final Offering Circular that forms a part of the Offering Statement may be obtained from: https://www.startengine.com/mybutterflyai.

For questions contact myButterfly.AI at info@mybutterfly.ai

Share article on social media or email:

DVAC Submits Comment Letter Asking CMS To Stop “Historic” Cuts


News Image

www.dialysisvascularaccess.org

As drafted, this rule will reduce patient options for life-saving care because vascular access centers will be forced to close due to insufficient reimbursement levels.

Today, the Dialysis Vascular Access Coalition (DVAC) sent a comment letter to the Centers for Medicare and Medicaid Services (CMS) on the proposed changes to

the 2023 Physician Fee Schedule (CMS-1770-P).

The DVAC comment letter stresses that the repeated cuts to office-based specialists under the Physician Fee Schedule are contributing to office-based center closures, health system consolidation and, as a result, are undermining the Biden administration’s efforts to address health equity issues.

CLICK HERE TO READ THE COMMENT LETTER.

In the letter, DVAC states, “We believe another round of office-based dialysis vascular access center closures not only would be likely to drive vascular access repair utilization lower, such closures also would begin to drive utilization back to the hospital. Not only would such a result obviously cost Medicare patients and the Medicare program much more, but it would also further undermine patient outcomes given that peer reviewed data has shown that patients who receive vascular access care in the office have better outcomes than those patients treated in the hospital outpatient setting.

It continues, “The 2023 PFS Proposed Rule continues these historical cuts to office-based specialists by reducing the 2023 Medicare conversion factor by about 4.5% from $34.6062 to $33.0775.”

Dr. Dean Preddie, DVAC’s policy chair, said, “As drafted, this rule will reduce patient options for life-saving care because vascular access centers will be forced to close due to insufficient reimbursement levels. We’ve already seen this horror movie and we know how it ends. DVAC is asking Congress to work with CMS on fundamental reforms and to drop these new cuts to the MPFS.”

DVAC is a coalition of entities that provide vascular access services to individuals with advanced kidney disease and End-Stage Renal Disease (ESRD).

Share article on social media or email:

Safr Care Announces the Appointment of Gregg Kunemund to the Board of Advisors


News Image

“Serving on the Board of Advisors for Safr Care will allow me to focus on non-urgent transportation services, ensuring that access to healthcare is available for everyone regardless of age or income.”

Safr Care is pleased to announce Gregg Kunemund has joined the Safr Care Board of Advisors.

An accomplished healthcare and insurance specialist, Mr. Kunemund has more than three decades of experience in strategic consulting and specialized business Health Care solutions. As the Health Plan Chief Executive Officer (CEO) for United Healthcare Medicare & Retirement, Mr. Kunemund was responsible for organizing and managing relationships across healthcare regulators and providers, claims management services, service operations, and medical management entities. He previously served as Manager of Medicare Group Retiree & Individual Products Operations for BCBS Florida, as well as AvMed Director of Medicare & Medicaid Products & Service Operations. As of 2022, Mr. Kunemund founded and serves as President and CEO of GK Healthcare Consulting Group, consulting on government-sponsored health plans and specialized business Health Care solutions.

“Gregg’s expansive knowledge of regulatory, provider, claims, service operations, and medical management will be invaluable as Safr Care endeavors to streamline the non-emergency medical transportation (NEMT) system and eradicate the $150 billion annual loss to the US healthcare system due to patient no-shows to their medical appointments,” says Safr Care CEO, Syed Gilani. “His expertise and experience with government healthcare programs will help Safr Care remain compliant with rapidly changing state and federal regulatory conditions.”

“Throughout my 30+ year career I have always looked to improve health outcomes,” says Mr. Kunemund. “Serving on the Board of Advisors for Safr Care will allow me to focus on non-urgent transportation services, ensuring that access to healthcare is available for everyone regardless of age or income.”

Safr Care’s next-generation transportation management platform delivers a comprehensive software solution for hospitals, nursing and managed care and other healthcare facilities in need of ambulatory and wheelchair-accessible medical transportation service. A growing network of healthcare facilities, transportation brokers and transportation providers use Safr Care to manage their transactions, streamline scheduling, and monitor rides to assure the highest quality transportation for patients.

About Safr Care:

Safr Care is a healthcare technology platform focused on the Non-Emergency Medical Transportation (NEMT) market. The mission of Safr Care is to help improve the healthcare transportation market while empowering women. Safr has been at the forefront of transportation technology since 2017. See https://safrcare.com

Share article on social media or email:

IVFusionMD Now Offering Seattle Bellevue Residents Premier Intravenous Therapy Service


Seattle- IVFusionMD – IVFusionMD clinics are currently offering intravenous therapy infusions of medications, vitamins, supplements, electrolytes and rehydration fluids to patients of the Pacific Northwest and Puget Sound area. IVFusionMD is a physician-founded and physician-run IV infusion medication and vitamin therapy clinic. All formulations have been designed by our own highly trained physicians who have extensive scientific research backgrounds and all therapies are overseen directly by our own physicians to ensure quality and safety. There are three locations including Kirkland, Bellevue, and Auburn, which serve the greater Seattle-Tacoma-Bellevue metro area.

IVFusionMD’s focus is on health and wellness and treating patients with the latest IV intravenous infusion therapies to help achieve patient’s individual goals. However IVFusionMD differentiates itself by using research based ingredient formulations and sourcing the best essential fluids, electrolytes, vitamins, medications and antioxidants. IVFusionMD offers the best high quality, U.S. made, and preservative-free vitamin options for the most discerning patients.

IVFusionMD’s 20 different infusion formulations are aimed to help maximize health and wellness which targets performance recovery, enhancing of skin tone and clarity and brightness, supporting of immunity system functions, recovering from illness,treating migraines or resetting jet lag via Myer’s cocktail, and helping with key metabolic vitamins involved in weight loss at any of the three locations. Not only does IVFusionMD offer vitamin infusions for goals of general wellness, there are also offerings to help with specific issues such as acute intractable migraine headaches, acute G.I. illness or hangover, dehydration, B vitamin deficiency such as commonly seen in numerous medical conditions including anemia and post bariatric surgery patients, post exercise fatigue, exhaustion related to travel or sickness, stimulating metabolism, neuropathy, and immune system enhancement. Patients with long COVID have been seeking out services, such as high dose vitamin C infusions, glutathione infusions, and B12 injections.

IVFusionMD also offers up-to-date research based vitamin and supplement infusions with IV glutathione. Glutathione is a naturally occurring antioxidant that gets depleted when there’s stress or illness. Glutathione has been shown in research to enhance the evenness, brightness, and lightness of the skin. Patients with uneven darkness or dull looking skin say that they receive excellent skin brightening, evenness and clarity from IV glutathione infusions.

Patients also seek our intravenous infusions due to acute migraine headaches, and we provide a similar service for treatment of other headaches that one may seek in an urgent state. Our headache or migraine IV intravenous infusions are formulated with the goals of rehydration, anti-inflammation, and anti-nausea medications,to help break an acute migraine headache episode.

“It is very satisfying to help a patient break a horrible migraine headache in under an hour,” Dr Mark Tseng reports. “If we can provide fast relief that no one else can, we can go home pretty proud that day.”

Additionally IVFusionMD also offers NAD+ infusions which many patients seek out for a metabolic kickstart, biohacking or perhaps for fertility issues. In clinical research, it has been shown that NAD+ declines with aging, and reduced NAD+ may be associated with signs of body aging. Low NAD+ is also associated with cellular degeneration. Some research demonstrates telomere lengthening due to NAD+, and telomere lengthening is associated with reversal of aging. During stress states, such as obesity, exhaustion, alcohol consumption, overeating, NAD+ is also reduced. Patients may seek out NAD+ supplementation as a method to reverse depletion either in the short term related to exhaustion, illness, or drinking, or as a method to artificially increase NAD+ to entice a metabolically pro-active state.

Female patients have been referred by their infertility specialists to try NAD+ infusions as a part of the fertility journey. The NAD+ can be found in either the NAD+ infusion or the BioHack Me infusion. IVFusionMD only uses high-quality U.S. specialty pharmacy sourced NAD+ to ensure top quality.

Interestingly, since opening, IVFusionMD has seen numerous referrals from oncologists and infectious disease doctors who wish to have their patients try a high-dose vitamin C infusion, either as a supplement for their cancer treatment or for long COVID related illness or fatigue or as an adjunct for palliative care. Though we do not have thorough research into whether these different treatment options may help the above conditions, there are some emerging pre-clinical research and case reports in the literature that support a possible role of high-dose vitamin C for otherwise refractory and terminal conditions. According to literature, IV therapy for high-dose vitamin C is the only method to achieve a high level of vitamin C in the plasma, as oral supplemental vitamin C must go through the digestive tract which limits absorption of vitamin C into the bloodstream. IVFusionMD offers three different doses for our vitamin C infusion to allow flexibility to patients.

Personal case reports of many patients state they do well with fatigue and prolonged illness recovery due to vitamin C infusion, however medical data to support this is unclear and needs further clinical trials. Unfortunately, ways to recover from long COVID symptoms are too new and not described by any literate at this point however we provide the means so that patients may safely utilize if his or her own personal research has led to wanting to try such infusions of essential vitamins that may be depleted in chronic illness and fatigue conditions.

“Now more than ever, research is showing the value of certain vitamins and supplements that can only be achieved via intravenous therapies to complement one’s health.” says Dr. Bowers MD, Co-founder of IVFusionMD.

For more information, visit: http://www.ivfusionmd.com

Share article on social media or email:

Tucson Criminal Defense Attorney Becomes Fourth Woman in the United States to Earn DUI Defense Certification


Tucson Criminal Defense Attorney Michelle Behan Earns DUI Board Certification, 2022.

Behan Law Group is proud to announce that founding attorney Michelle Behan has earned her board certification in DUI Defense. Attorney Behan is the only woman in the state of Arizona to hold this certification and the fourth woman to do so in the entirety of the United States. Ms. Behan, who opened Behan Law Group in 2017, received the certification through the National College of DUI Defense (NCDD).

Michelle Behan has dedicated the majority of her career to providing knowledgeable legal services to individuals who have been charged with driving under the influence, including first-time DUI, extreme DUI, and underage DUI offenses. Additionally, she handles cases involving an array of other criminal charges, including drug crimes, theft, sexual offenses, and white-collar crimes.

A United States Navy Veteran and a former FBI Special Agent, Attorney Behan is an active member of the NCDD. She is a lecturer and faculty member, writing amicus briefs on the Amicus Committee, and she also serves as the NCDD State Delegate for Arizona. Outside of the NCDD, Michelle Behan holds membership with the DWI Committee of the National Association of Criminal Defense Lawyers, and she also serves as an associate member of the American Academy of Forensic Sciences.

Michelle Behan’s tireless work ethic and commitment to her clients have aided her in obtaining a long list of accomplishments. After two years of working on an international parental kidnapping case, Attorney Behan received national recognition from the National Center for Missing and Exploited Children. In 2015, Attorney Behan received the Tucson Women’s Commission Rising Star Award while working as an assistant public defender. Michelle has also been recognized by Avvo and Expertise.com, and she was recently named a 2022 Elite Lawyer.

About Behan Law Group

The legal team at Behan Law Group helps individuals in Tucson and throughout Pima County with legal matters related to DUI and criminal defense. Attorney Behan and her team prioritize staying up to date on laws related to DUI and criminal matters in Arizona. Behan Law Group is comprised of skilled team members who are ready to take on your case, protect your rights, and fight to help you avoid a conviction.

To learn more about Michelle Behan and her criminal defense firm, visit https://www.missduiarizona.com/. Prospective clients can speak with our team and schedule a consultation with an attorney by calling 520-220-5047.

Share article on social media or email:

Congratulations to our SightMD 2022 Castle Connolly Top Doctors


News Image

“It’s always special to receive an award. To be honored by my peers is incredibly gratifying.” said Dr Knoll “I am also grateful to the talented and dedicated staff I work with. In the end, it’s about providing quality patient care.”

Castle Connolly announced its “2022 Top Doctors,” a list that represents the top seven percent of doctors in the nation. SightMD is proud to announce that 19 of their physicians are among these standouts. SightMD’s “Top Doctors” are: Dr. Alexander Hatsis, Dr. Allen Greenbaum, Dr. David Immanuel, Dr. Faye Knoll, Dr. Irene Magramm, Dr. James Gordon, Dr. Jeffrey Martin, Dr. John Mauro, Dr. Laurence Rubin, Dr. Lawrence Buono, Dr. Lawrence Zweibel, Dr. Michelle Liebert, Dr. Norman Saffra, Dr. Paul Choinski, Dr. Paul Sforza, Dr. Richard Nattis, Dr. Seth Potash, Dr. Ted Karl and Dr. William Kasper.

These outstanding doctors were nominated by their peers and thoroughly validated by Castle Connolly’s research team to ensure that they deliver the highest quality patient care. The 2022 list is the largest ever, as it included more than 61,000 physicians across all specialties in every major metropolitan market.

Dr. Alexander Hatsis is a board certified ophthalmologist specializing in complicated cataracts and laser vision correction. He was one of the expert U.S. surgeons to help gain FDA-approval for laser vision correction and was the first surgeon to perform LASIK on Long Island in 1995.

Dr Allen S. Greenbaum is a board-certified ophthalmologist serving the Westchester community. Dr. Greenbaum is a comprehensive ophthalmologist, with a special interest in refractive cataract surgery, including laser cataract surgery with premium lens implants.

Dr. David Immanuel is a board certified ophthalmologist specializing in laser cataract surgery with advanced technology lenses and laser vision correction (LASIK and PRK). He is also a cornea and external disease specialist with expertise in corneal transplants and pterygium excisions. He received both MD and PhD degrees from the Medical Scientist Program at NYU and has trained many ophthalmology residents at Nassau University Medical Center.

Dr. Faye Knoll is a board certified ophthalmologist specializing in both laser and traditional cataract surgery as well as laser vision correction including LASIK and PRK. Dr Knoll completed a fellowship at the New York Eye and Ear Infirmary in cornea and external diseases of the eye. “It’s always special to receive an award. To be honored by my peers is incredibly gratifying.” said Dr Knoll “I am also grateful to the talented and dedicated staff I work with. In the end, it’s about providing quality patient care.” Dr. Knoll has been a part of the SightMD team since 2012. Her favorite part of her job is developing lifelong relationships with her patients.

Dr. Irene Magramm is a board certified ophthalmologist specializing in strabismus surgery and relief of double vision in children and adults. She also enjoys general ophthalmology in children and adults.

Dr. James R. Gordon is a board certified ophthalmologist and oculofacial surgeon with over 20 years of experience. He has particular expertise in the handling of challenging and complex cases. He has published numerous papers and has given extensive lectures on ocular disease and eyelids and facial cosmetic procedures, including innovative techniques for fillers & injectables.

Dr. Jeffrey Martin is a board certified ophthalmologist and is President and Co-Founder of SightMD. Dr. Martin joined his father’s ophthalmology practice in 1997 and is proud to have helped it become a regional leader in eye care. “I am thrilled every day to have the privilege of caring for my patients.” said Dr Martin “ Being recognized by Castle Connolly is an honor.” Dr. Martin is a specialist in both LASIK and cataract surgery.

Dr. John Mauro is a board certified ophthalmologist specializing in cataract and LASIK vision correction surgery. He is driven to provide exceptional eyesight to his patients and make them feel as comfortable as possible throughout their eyecare journey. “It is a prestigious honor and a privilege to be recognized by Castle Connolly” said Dr Mauro

Dr. Laurence Rubin is a board certified ophthalmologist with over 25 years of experience in comprehensive eye care. Dr. Rubin strives to provide the highest quality eye care by carefully listening to and observing every patient he sees.

Dr. Lawrence Buono is a board certified ophthalmologist that treats all medical and surgical conditions of the eye. As the attending neuro-ophthalmologist at the Duke Eye Center, he had the opportunity to care for patients with complex neuro-ophthalmic conditions and worked closely with the Department of Neurosurgery at the Duke University Brain Tumor Center.

Dr. Michelle Liebert is a board certified pediatric ophthalmologist specializing in strabismus surgery. Dr. Liebert takes a personal interest in each and every one of her patients, caring for each as if they were her own. One of her favorite aspects of being a doctor is that she can follow her patients from prematurity until adulthood.

Dr. Norman Saffra is one of the nation’s leading ophthalmic laser and microsurgeons and is known for his expertise in treating diseases that cause visual loss. “It is such a great honor to be recognized by Castle Connolly for over two decades” said Dr Saffra. Dr Saffra is an expert in conditions affecting the posterior segment of the eye, specifically those that involve the optic nerve, or the retina and vitreous.

Dr. Paul A. Choinski is a board-certified ophthalmologist who has over 30 years of medical and surgical experience in private practice as an eye doctor in Eastern Long Island. “I feel very honored and flattered to be recognized by Castle Connolly for my 32 years of eye care for the eastern Long Island community” said Dr Choinski. Dr Choinski practices comprehensive ophthalmology with an emphasis on cataract surgery including the use of femtosecond cataract surgery and advanced intraocular lens implant technologies. Dr Choinski loves to see patients leave with a smile on their face.

Dr. Paul Sforza is a board certified fellowship-trained Cornea specialist with special training and interest in femtosecond laser assisted cataract surgery, premium intraocular lenses, and laser vision correction (LASIK/PRK). Dr Sforza is known for performing cutting-edge surgery with a warm bedside manner.

Dr. Richard Nattis is a board certified ophthalmologist specializing in cataract and laser vision correction surgery. Dr. Nattis has been performing laser refractive surgery (PRK-LASIK) since it was approved by the FDA in 1995. “It is humbling and a great honor to be on this list for over 20 years.” said Dr. Nattis “To be recognized by fellow physicians consistently is evidence of excellent patient care and gives credit to my personal, compassionate and advanced treatment of my patients.” Dr. Nattis actively teaches medical and emergency room resident physicians, as well as medical students interested in Ophthalmology.

Dr. Seth D. Potash is a Board Certified Ophthalmologist and fellowship-trained Glaucoma specialist proudly serving the Westchester community. “Professionally speaking, the two most important things to me is to provide outstanding patient care and be respected by my peers.” said Dr. Potash “It is such a nice honor to be named to Castle Connolly’s Top Doctor List because this award is purely based on recognition and the recommendations from my medical colleagues.” Dr. Potash specializes in glaucoma subspecialty care and cataract surgery, both routine and complex, and has performed thousands of laser and surgical procedures.

Dr. Ted Karl is a board certified ophthalmologist who combines his vast experience with his dedicated skill to provide high quality eye care to all of his patients.

Dr. William Kasper is a board certified ophthalmologist who emphasized the importance of early diagnosis and treatment of ocular disorders. He is an active member of the local ophthalmology community, contributing to the scientific and educational information of several ophthalmologic societies, and training residents in the art and science of the specialty at the Nassau County Medical Center.

When compiling the list, Castle Connolly’s research team thoroughly vets each physician’s professional qualifications, education, hospital and faculty appointments, research leadership, reputation, disciplinary history and, if available, data outcomes. Additionally, a physician’s interpersonal skills—such as listening and communicating effectively, demonstration of empathy, and instilling trust and confidence—are also considered in the review process. The Castle Connolly Doctor Directory is the largest network of peer-nominated physicians. These “Top Doctors” are among the most highly sought-after medical professionals in their communities.

SightMD prides itself on having more Castle Connolly “Top Doctors” than any other practice in New York, and are thrilled to announce this year’s list and recognize all of our hard working physicians.

About Castle Connolly

With over 25 years’ experience in researching, reviewing and selecting “Top Doctors,” Castle Connolly is a trusted and credible source. In fact, a 2018 study that was published in the “Journal of Medical Research” found that across several specialties, Castle Connolly’s peer-reviewed directory was much more reliable than sites which just relied on patient reviews when it came to identifying quality care. Castle Connolly’s mission is to help people find the best healthcare by connecting patients with best-in-class providers. For more information, visit https://www.castleconnolly.com.

About SightMD

SightMD is a rapidly-growing integrated ophthalmic provider group that offers patients access to over 80 eye care providers through the convenience of 40 locations across New York. SightMD’s track record of providing clinically-excellent care spans over 50 years, and its services include general eye exams, laser cataract surgery and lens implantation, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, LASIK laser vision correction, oculoplastic surgery, pediatric ophthalmology, and audiology. Sight Growth Partners is the administrative services provider for SightMD. For more information about SightMD, please visit https://www.sightmd.com/sightmd-ny/

Cannabiz Media Wins 2022 Green Market Report Cannabis Technology Award for Best Platform Design


Cannabiz Media

Cannabiz Media Wins 2022 Green Market Report Cannabis Technology Award for Best Platform Design

“It’s an honor to be recognized as an outstanding platform in an industry that is filled with creative innovators who share the same goal – to further access to legal cannabis products,” said Ed Keating, Cannabiz Media co-founder and Chief Data Officer.

Cannabiz Media, the company behind the leading License Database of cannabis and hemp data used to enhance sales and marketing strategies and enable financial analysis and reporting, has won the 2022 Tech Award for Best Platform Design from Green Market Report, a Crain’s Communications brand.

The Green Market Report Cannabis Technology Awards honor companies that have developed unique and innovative solutions to challenges within the cannabis industry. Cannabiz Media’s platform has enabled stakeholders in the cannabis industry to connect, grow their businesses, and expand their markets.

“It’s an honor to be recognized as an outstanding platform in an industry that is filled with creative innovators who share the same goal – to further access to legal cannabis products,” said Ed Keating, Cannabiz Media co-founder and Chief Data Officer. “We built the Cannabiz Media License Database for sales and marketing as well as Cannabiz Intelligence for financial analysis and research. Both have grown considerably with new features added all the time that make it easier for our clients to do their jobs and reach their goals.”

In 2022, Cannabiz Media launched significant updates to its platform that streamlined the way businesses can connect with license holders, investors can track mergers and acquisitions, and more. “In the past 12 months,” shares Keating, “we added essential reports and integrations to the Cannabiz Media platform, including patient data and wholesale cannabis prices. We’re tracking more than 70,000 licensed cannabis and hemp operations, and more enhancements and additions are coming in 2023.”

The 2022 Green Market Cannabis Technology Award winners were determined by a panel of industry judges, and awards were presented during Green Market Report’s 2022 Tech Summit in San Francisco on September 8, 2022. Cannabiz Media’s Vice President of Sales, Davis Thode, accepted the award at the Tech Awards Reception.

About Cannabiz Media

Cannabiz Media manages the leading License Database of cannabis and hemp license holder data containing verified information on over 40,000 licensed cannabis and 30,000 licensed hemp operations across the United States, Canada, and numerous international markets. Subscribers can access this data through an easy-to-use platform in multiple ways. Sales and marketing teams can find contact information for license holders, segment their target audiences, and then tap into a powerful email marketing tool. And financial analysts, investors, and legal advisors can leverage Cannabiz Intelligence to conduct comprehensive financial analysis, target mergers and acquisitions (M&A), and research valuations. Cannabiz Media was established in 2015.

Share article on social media or email:

Todd Wyatt Joins Summit BHC, A Leading National Provider Of Behavioral Health and Addiction Treatment Services, as Chief Financial Officer


Summit BHC (Summit), a leading national provider of behavioral health and addiction treatment services based in Franklin, Tennessee, has named Todd Wyatt as Chief Financial Officer.

“Todd brings a wealth of financial knowledge and experience in high-growth healthcare service companies,” said Brent Turner, CEO of Summit. “His extensive healthcare experience will be a valuable asset for Summit. We are excited to have him join our leadership team as we continue to advance our position in the behavioral health industry.”

Wyatt comes to Summit from Conifer Health Solutions in Frisco, Texas, where he served as Senior Vice President and Chief Financial Officer.

“I am excited to join the talented team at Summit and help to fulfill their vision for the future of behavioral healthcare,” said Wyatt. “I see a promising, growth-filled future for Summit with caring people, an innovative culture, and expanding company footprint.”

Before his time with Conifer, Wyatt spent 14 years with Acelity in various financial leadership roles, including Chief Financial Officer and Senior Vice President of Business Transformation. Wyatt’s prior experience has included capital markets transactions, mergers, acquisitions, information technology, business transformation, and investor relations.

About Summit

Headquartered in Franklin, Tennessee, Summit operates a leading national network of behavioral health hospitals and addiction treatment centers throughout the country. The company’s primary focus is on psychiatric and substance use disorder treatment within a flexible and dynamic continuum of care. The leadership team at Summit is composed of senior executives with decades of combined experience in the behavioral healthcare industry. The company currently owns and operates 32 inpatient facilities nationwide.

For Information:

Mike Alday

Alday PR

615-791-1535 x22

mike@aldaypr.com

Share article on social media or email:

Greenberg Traurig’s David J. Dykeman Named “Patent Strategy Attorney of the Year – Massachusetts” by LMG Life Sciences


David J. Dykeman Named “Patent Strategy Attorney of the Year – Massachusetts” by LMG Life Sciences

“The life sciences industry has always been an important part of Greenberg Traurig’s global practice, and this recognition highlights the firm’s strong commitment to our innovative clients,” said Richard A. Rosenbaum, Greenberg Traurig’s Executive Chairman.

David J. Dykeman, co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group, and co-managing shareholder of the firm’s Boston office has been named “Patent Strategy Attorney of the Year – Massachusetts” by LMG Life Sciences. Winners were announced at an awards dinner in New York City on Sept. 8.

Additionally, Lori G. Cohen, who is vice chair of Greenberg Traurig and co-chair of the firm’s Global Litigation Practice and its Trial Practice, was shortlisted for the LMG Life Sciences Product Liability Attorney of the Year award.

“The life sciences industry has always been an important part of Greenberg Traurig’s global practice, and this recognition highlights the firm’s strong commitment to our innovative clients,” said Richard A. Rosenbaum, Greenberg Traurig’s Executive Chairman.

“Massachusetts is one of the thriving hubs for life sciences and medical technology companies, and Dave Dykeman is a go-to patent attorney for innovators in that region and across the country and globe,” said Wayne H. Elowe, co-chair of the firm’s global Life Sciences & Medical Technology Group.

LMG Life Sciences is considered the definitive guide to leading U.S., Canada, Europe, Middle East, and Africa law firms and lawyers specializing in the life sciences industry. The guide’s LMG Life Sciences Awards recognize key law firms, lawyers, and the innovative work accomplished throughout the life sciences industry. They are based on marketplace and client feedback, as well as information provided by firms, which can only be ranked if the market deems them worthy of consideration.

A registered patent attorney with 25 years of experience in patent and intellectual property law, Dykeman has been listed as an LMG Life Sciences Star since 2014. His practice focuses on securing worldwide intellectual property protection and related business strategy for high tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. Dykeman provides strategic patent portfolio development and intellectual property advice for clients, including major research institutions, multinational corporations, and early stage companies. He also performs patent due diligence to assess patent portfolios for venture capital investment, mergers and acquisitions, and licensing opportunities. An author of over 55 articles and a speaker at over 50 conferences on intellectual property law, Dykeman is the founding co-chair of the American Bar Association’s Medical Devices Committee.

About Greenberg Traurig’s Boston Office: Established in 1999, Greenberg Traurig’s Boston office is home to more than 80 attorneys practicing in the areas of bankruptcy and restructuring, corporate, emerging technology, energy, environmental, financial services, gaming, governmental affairs, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, real estate, and tax. An important contributor to the firm’s international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. The team offers clients the value of decades of helping clients in complex legal matters and hands-on knowledge of the local business community, supported by the firm’s vast network of global resources.

About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig: Greenberg Traurig, LLP has more than 2500 attorneys in 43 locations in the United States, Europe, Latin America, Asia, and the Middle East. The firm reported gross revenue of over $2 Billion for FY 2021 and is consistently among the top firms on the Am Law 100, Am Law Global 100, and NLJ 250. On the debut 2022 Law360 Pulse Leaderboard, it is a Top 15 firm. Greenberg Traurig is Mansfield Rule 4.0 Certified Plus by The Diversity Lab and the Center for Resource Solutions Green-e® Energy program certifies that the firm’s U.S. offices are 100% powered by renewable energy. The firm is often recognized for its focus on philanthropic giving, innovation, diversity, and pro bono. Web: http://www.gtlaw.com.

Share article on social media or email:

Healthy Aging and Well-being with Mediterranean Fruit and Vegetable Extracts — Part 1, Upcoming Webinar Hosted by Xtalks


Increased demand, in combination with recent disruptions in supply chains, has led to a heightened risk for sub-standard or adulterated ingredients with wild claims and regulatory issues entering the supply chain.

The market is more receptive to products that are as natural as possible and with similar health promoting value as the foods consumers eat up. Not to be neglected is the desire for plant-based, sustainable products that benefit healthy aging, well-being and the environment. Increased demand, in combination with recent disruptions in supply chains, has led to a heightened risk for sub-standard or adulterated ingredients with wild claims and regulatory issues entering the supply chain.

Responding to a growing demand for premium, eco-friendly, clean and sustainable botanical ingredients for the health-aware and environmentally conscious aging consumers, Spain-based global supplier of pharma-grade botanicals developed the Mediterranean fruit and vegetables extracts™. These premium standardized ingredients are inspired by the health-promoting and trendy Mediterranean diet in practical formats, backed by published studies and ongoing research on healthy aging applications such as cardiovascular, metabolic, cognitive and mood support, sports nutrition, mobility and beauty from within.

With this new line of extracts, Euromed dives deep into locally sourced, edible Mediterranean fruits and vegetables that are staple in the Mediterranean diet.

This webinar will provide valuable information and solutions for a market demanding transparency with regards to how health supplements are produced, a market that prefers certified organic, clean and ecological technologies reducing the risk of chemical residuals and harm to consumer’s health and the environment, delivering on claims relating to health, quality, provenance and sustainability.

Join this webinar to learn more about how holistic, botanical ingredients from a Mediterranean diet can benefit well-being and healthy aging.

Join Dott. Andrea Zangara, Head of Scientific Communications and Marketing, Euromed; Dr. Emad Al-Dujaili, Professor in Clinical and Medical Biochemistry, Queen’s Medical Research Institute, University of Edinburgh, Scotland, UK; and Fredy Silva Fuentes MSc, Scientific Communications and Marketing, Euromed, for the live webinar on Thursday, September 22, 2022, at 10am EDT (3pm BST/UK).

For more information, or to register for this event, visit Healthy Aging and Well-being with Mediterranean Fruit and Vegetable Extracts — Part 1.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email: